Blue Horseshoe Stocks: PZOO Recap, Marijuana Legalized in Two More States

Pazoo, Inc. PZOO

PZOO continues to command our attention this week; for those of you who may not remember, we introduced this play on October 20th at which time it was trading hands at a low of .0225.

The last time we looked in on PZOO, it had been making progress, and we mentioned that our key area of resistance was at .038. Yesterday’s session brought a break of that barrier, as we saw the stock run up to a new high of .042. That marks an 87% overall move up over a span of a dozen sessions.  As it stands now, the next primary area of resistance the stock has to contend with sits at a nickel.

The surge on the chart is just one of the developments which has occurred in the weeks since we first caught it. The company also announced the expansion of its online information network with the introduction of new portals at PAZOOFINANCE.COM and PAZOOFITNESS.COM.

In addition, we received an update on Pazoo’s connection to the medical marijuana sector, cannabis testing firm MA & Associates. First announced on Monday, the firm has linked up with Steep Hill Labs, which already operates testing facilities in other states. MA & Associates will be dually billed as Steep Hill Nevada, and has just received the green-light from the State of Nevada, becoming  one of the first testing facilities to receive an official State License to test and analyze medical marijuana for Nevada’s recently-adopted program. >> Official PR


Marijuana Initiatives Pass in AK, OR & D.C.

Over the last few months, we’ve frequently been reminding our readers to pay attention to votes on cannabis initiatives that were coming up in several jurisdictions. On Tuesday, voters in two more states and the nation’s capital (pending congressional approval) green-lighted recreational marijuana.

It’s going to accelerate the spread of what we’ve been calling the beginning of the end for pot prohibition, not to mention shine an even brighter light on the cannabis sector, which has already begun to pick up steam of late.

Each time marijuana proponents strike a victory blow, we share in the satisfaction. After all, we’ve been touting the sector for even longer than the mainstream media. Our coverage spans further back than even the first passed measures, all the way back to 2012. We’ll be sure to keep following the whole story along with our mammoth list of tracked pot stocks, and pass along any developments to you.


Morning Gappers:

Vapor Corp. VPCO

YOU On Demand Holdings, Inc. YOD

We caught both of these stock gapping up in the premarket this morning that we think are worth watching as the session kicks off. VPCO is gapping up approximately 8% while YOD is up a full 15% in early trading.


Extended Watchlist:
CBIS, HEMP, ERBB, GRNH, TRTC

Blue Horseshoe Stocks: NYMX Update, LTNC & More

Nymox Pharmaceutical Corp. NYMX

We certainly hope our readers read over yesterday’s morning report thoroughly, because it would mean that people caught our closing note on NYMX in the extended watchlist. We mentioned the big gap-down on the stock, and that we’d be on the lookout for a reversal.

It didn’t take any time at all for NYMX to behave according to our suspicions; it opened at a low of .59 and immediately began its recovery, which lasted for a good portion of the day and culminated in a high of 1.03. Big congratulations are in order for anyone that took advantage of that 74% intraday rip.

The huge gap-down was apparently caused from a knee-jerk reaction to Sunday’s announcement that the company’s prostate cancer treatment (NX-1207) failed to meet primary efficacy endpoints in Phase 3 studies.

It’s fair to mention that prior to yesterday’s session, NYMX was trading at a base level just below $5 (50DMA of 4.77) and yesterday’s bottom-bounce carried it back up to a mere fraction of that level, so it will be interesting to see how much of its lost ground could potentially be recovered in coming sessions.


Labor Smart Inc. LTNC

We caught LTNC on a routine news scan this morning, and we really like what we learned from a quick glance at the PR. LTNC announced that its October revenues set a company record ($2.7M), contributed to a 23-month streak of year-over-year increases, and brought total revenue for 2014 over the $20M-mark.

Those highlights are substantial enough to have us put LTNC on our radar moving forward. A company exhibiting growth patterns like these is certainly worth watching.

The chart is also coming off of a relative bottom, so it could be that we’ve stumbled across LTNC at just the right time.


Extended Watchlist:
CDTI, CDVI, ODP, VSR, MWW, FCEL

Blue Horseshoe Stocks: FCGD, PZOO Updates

First Columbia Gold Corp. FCGD

FCGD continued to push its limits on Friday; if you recall, the low we observed following our in our initial report last Monday was .075. We witnessed a subsequent run to .098, which was followed by a pullback to support at  .076. From that level on Friday, FCGD went to to set a new high in to the close (.105), an intraday gain of 38% on nearly twice the monthly average volume.

LINKS:

Our Exclusive Interview with FCGD’s New CEO Jason Castenir on Thursday provided over 20 minutes of exclusive content on FCGD, so go check it out.

View a copy of Monday’s Initial FCGD Report Here

MORE INFO @ FirstColombiaGold.com
or connect with FCGD on Facebook, Twitter and YouTube


Pazoo, Inc. PZOO

We’ve kept an active eye on PZOO since we introduced it to our reports two Mondays ago at a low of .0225. The stock has since established a higher level of support above the 50DMA, which was something we were looking to have happen.

We also saw PZOO achieve a new high last week, hitting .038 (A 69% increase from our observed low) a mark that will act as key resistance moving forward.

The company set a new traffic milestone for their online health and wellness portal as well, updating us of the achievement on Thursday:

WHIPPANY, NJ / ACCESSWIRE / October 30, 2014 / Pazoo, Inc. (PZOO) (German WKN#: A1J3DK) is pleased to report that traffic surged passed the previous high of 203,000 visitors in one day (previously recorded May of 2014) to 239,786 on October 27, 2014, as reported by Google Analytics. >> VIEW PR


Groupon, Inc. GRPN

We also need to pat ourselves on the back for taking a timely look at GRPN on Friday and mentioning it in our extended watchlist. The stock surged from a low of 6.45 and ended up peaking at 7.42, gaining 16.5% intraday on almost six times the one-month average volume.

That’s quite a respectable single-session spike from a stock in this price range.


Extended Watchlist:
GERN, OIBR, ARNA, MNDO, NYMX(Gap-down, Watching for Possible Reversal)